Widespread and constitutive inhibition of interferon-α/β receptor (IFNAR) signaling, as in the case of IFNAR−/− mice or the use of IFNAR-blocking antibodies, would be expected to have pleiotropic effects on tumor growth kinetics and leukocyte function. This evidence concerns the gene IFNAR1 and neoplasm.